MCL1 and melanoma: A recent study demonstrated that ABT-737 induces cell death in melanoma cell lines when combined with proteasome inhibitor MG-132 [22] The authors also perform an experiment indicating that ABT-737-dependent cell death can be enhanced by knockdown of Mcl-1.